2018•PubMedRequires access

[The influence of molecular classification of breast cancer on the safety of breast-conserving surgery].

Yun Li, Lan Mu, Yuxia Ruan, Yuting Wang, Di Zhang, Hao Xuan Zhou, Xin Wang

Abstract

Breast conserving therapy does not increase the risks of local recurrence and death of HER-2-positive and Triple-negative breast cancer patients. Therefore, breast conserving therapy can be accepted by patients with HER-2-positive and Triple-negative breast cancer.

About this research paper

What this paper is about

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Medicine, Breast cancer, Pathological, Breast-conserving surgery, Internal medicine, Stage (stratigraphy), Oncology, Metastasis